MyAverix Finance
HK · Healthcare
Clover Biopharmaceuticals Ltd (2197)
Biotechnology
Clover Biopharmaceuticals Ltd (2197) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $3.32B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2197
Clover Biopharmaceuticals Ltd (2197) — FAQ
What is Clover Biopharmaceuticals Ltd's market cap?
Clover Biopharmaceuticals Ltd (2197) has a reported market cap of $3.32B (data as of 2026-05-21).
What is 2197's P/E ratio?
The price-to-earnings (P/E) ratio for Clover Biopharmaceuticals Ltd (2197) is 18.00 (data as of 2026-05-21).
Does Clover Biopharmaceuticals Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Clover Biopharmaceuticals Ltd (2197). Check the MyAverix Finance app for the latest dividend data.
What sector is Clover Biopharmaceuticals Ltd in?
Clover Biopharmaceuticals Ltd (2197) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2197 listed on?
2197 is listed on HK.
What is Clover Biopharmaceuticals Ltd's net margin?
Clover Biopharmaceuticals Ltd (2197) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.